Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response to olaparib in a PALB2 germline mutated prostate cancer and genetic events associated with resistance.
Horak P, Weischenfeldt J, von Amsberg G, Beyer B, Schütte A, Uhrig S, Gieldon L, Klink B, Feuerbach L, Hübschmann D, Kreutzfeldt S, Heining C, Maier S, Hutter B, Penzel R, Schlesner M, Eils R, Sauter G, Stenzinger A, Brors B, Schröck E, Glimm H, Fröhling S, Schlomm T. Horak P, et al. Among authors: von amsberg g. Cold Spring Harb Mol Case Stud. 2019 Apr 1;5(2):a003657. doi: 10.1101/mcs.a003657. Print 2019 Apr. Cold Spring Harb Mol Case Stud. 2019. PMID: 30833416 Free PMC article.
Prostate cancer prognosis in men with other malignancies prior to radical prostatectomy.
Klippenstein P, Schlomm T, von Amsberg G, Beyer B, Pompe RS, Michl U, Salomon G, Thederan I, Budäus L, Heinzer H, Tilki D, Haese A, Huland H, Graefen M, Steuber T, Tennstedt P. Klippenstein P, et al. Among authors: von amsberg g. Urol Oncol. 2019 Sep;37(9):575.e1-575.e7. doi: 10.1016/j.urolonc.2019.04.007. Epub 2019 Apr 30. Urol Oncol. 2019. PMID: 31047783
Efficacy and Mechanism of Action of Marine Alkaloid 3,10-Dibromofascaplysin in Drug-Resistant Prostate Cancer Cells.
Dyshlovoy SA, Kaune M, Hauschild J, Kriegs M, Hoffer K, Busenbender T, Smirnova PA, Zhidkov ME, Poverennaya EV, Oh-Hohenhorst SJ, Spirin PV, Prassolov VS, Tilki D, Bokemeyer C, Graefen M, von Amsberg G. Dyshlovoy SA, et al. Among authors: von amsberg g. Mar Drugs. 2020 Dec 1;18(12):609. doi: 10.3390/md18120609. Mar Drugs. 2020. PMID: 33271756 Free PMC article.
Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer.
von Amsberg G, Zilles M, Mansour W, Gild P, Alsdorf W, Kaune M, Böckelmann L, Hauschild J, Krisp C, Rohlfing T, Saygi C, Alawi M, Zielinski A, Langebrake C, Oh-Hohenhorst SJ, Perner S, Tilki D, Schlüter H, Graefen M, Dyshlovoy SA, Bokemeyer C. von Amsberg G, et al. Int J Mol Sci. 2022 Nov 29;23(23):14948. doi: 10.3390/ijms232314948. Int J Mol Sci. 2022. PMID: 36499277 Free PMC article.
Preclinical patient-derived modeling of castration-resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease.
Elsesy ME, Oh-Hohenhorst SJ, Oing C, Eckhardt A, Burdak-Rothkamm S, Alawi M, Müller C, Schüller U, Maurer T, von Amsberg G, Petersen C, Rothkamm K, Mansour WY. Elsesy ME, et al. Among authors: von amsberg g. Mol Oncol. 2023 Jun;17(6):1129-1147. doi: 10.1002/1878-0261.13382. Epub 2023 Mar 16. Mol Oncol. 2023. PMID: 36694344 Free PMC article.
The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancer.
Dyshlovoy SA, Menchinskaya ES, Venz S, Rast S, Amann K, Hauschild J, Otte K, Kalinin VI, Silchenko AS, Avilov SA, Alsdorf W, Madanchi R, Bokemeyer C, Schumacher U, Walther R, Aminin DL, Fedorov SN, Shubina LK, Stonik VA, Balabanov S, Honecker F, von Amsberg G. Dyshlovoy SA, et al. Among authors: von amsberg g. Int J Cancer. 2016 May 15;138(10):2450-65. doi: 10.1002/ijc.29977. Epub 2016 Jan 23. Int J Cancer. 2016. PMID: 26695519
Urupocidin C: a new marine guanidine alkaloid which selectively kills prostate cancer cells via mitochondria targeting.
Dyshlovoy SA, Kudryashova EK, Kaune M, Makarieva TN, Shubina LK, Busenbender T, Denisenko VA, Popov RS, Hauschild J, Fedorov SN, Bokemeyer C, Graefen M, Stonik VA, von Amsberg G. Dyshlovoy SA, et al. Among authors: von amsberg g. Sci Rep. 2020 Jun 17;10(1):9764. doi: 10.1038/s41598-020-66428-5. Sci Rep. 2020. PMID: 32555282 Free PMC article.
Activity of New Synthetic (2-Chloroethylthio)-1,4-naphthoquinones in Prostate Cancer Cells.
Dyshlovoy SA, Pelageev DN, Jakob LS, Borisova KL, Hauschild J, Busenbender T, Kaune M, Khmelevskaya EA, Graefen M, Bokemeyer C, Anufriev VP, von Amsberg G. Dyshlovoy SA, et al. Among authors: von amsberg g. Pharmaceuticals (Basel). 2021 Sep 22;14(10):949. doi: 10.3390/ph14100949. Pharmaceuticals (Basel). 2021. PMID: 34681173 Free PMC article.
107 results